ELI LILLY & Co — Director's Dealing 2013

Apr 29, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2013-04-29

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-29	Common Stock	S	3500	$56.33	Disposed	43880	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1511	Indirect
Common Stock	1502	Indirect
Common Stock	6218	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.